Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment

Blood. 1998 Jan 1;91(1):360-1.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / physiology
  • Adolescent
  • Erythropoiesis / drug effects
  • Erythropoietin / blood*
  • Erythropoietin / physiology
  • Female
  • Humans
  • Polycythemia / blood
  • Polycythemia / congenital
  • Polycythemia / drug therapy*
  • Purinergic P1 Receptor Antagonists*
  • Receptors, Purinergic P1 / physiology
  • Receptors, Transferrin / blood*
  • Second Messenger Systems / drug effects
  • Second Messenger Systems / physiology
  • Theophylline / pharmacology
  • Theophylline / therapeutic use*

Substances

  • Purinergic P1 Receptor Antagonists
  • Receptors, Purinergic P1
  • Receptors, Transferrin
  • Erythropoietin
  • Theophylline
  • Adenosine